The term, meaning fear of reptiles, is an amalgam of Greek, not Latin. Herpeto = from herpeton, which means reptile, or more literally a creeping thing. In turn herpeton grew out of the verb herpein which meant to creep.
Basaglar is biologically similar to Sanofiâs basal insulin Lantus (insulin glargine), including the same protein sequence and a similar glucose-lowering effect. While the FDA does not call it a âbiosimilarâ drug for regulatory reasons, it can essentially be thought of as an alternative form of Lantus.
Basaglar was not approved as a biosimilar because there are no insulin glargines currently licensed under the PHSA. Lantus, its reference product, was approved under a different law, the Federal Food, Drug, and Cosmetic Act, an FDA spokesperson told Medscape Medical News. Instead, the FDA calls Basaglar an example of a follow-on product. More information on the FDA's decision is available on the agency's website.